![Sergio Traversa](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Sergio Traversa
Vorstandsvorsitzender bei
RELMADA THERAPEUTICS, INC.
Vermögen: 9 Mio $ am 31.05.2026
Profil
Sergio Traversa is currently Chief Executive Officer & Director at Relmada Therapeutics, Inc. since 2019.
Former roles include President, Chief Executive Officer, CFO & Director at Cactus Ventures, Inc. in 2013; Chief Executive Officer & Director at Camp Nine, Inc.; Chief Executive Officer at Relmada Therapeutics, Inc. from 2012 to 2013; Chief Executive Officer at Medeor, Inc. from 2010 to 2012; Independent Director at Actinium Pharmaceuticals, Inc. from 2014 to 2017; Director at Actinium Pharmaceuticals, Inc.; Managing Director at ING Barings LLC; Marketing Manager-Hospital Business Unit at Eli Lilly & Co.; Area Manager-Southern Europe at Therakos LLC; Principal at Farmitalia Carlo Erba SRL; Principal at Ardana Capital Management LP; Head-Sales at Farmitalia Carlo Erba Ltd. Education includes an undergraduate degree from the University of Turin and an MBA from The Leonard N Stern School of Business.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
RELMADA THERAPEUTICS INC 1,24 % | 26.03.2026 | 1.300.000 ( 1,24 % ) | 9 Mio $ | 31.05.2026 |
Aktive Positionen von Sergio Traversa
| Unternehmen | Position | Beginn |
|---|---|---|
| RELMADA THERAPEUTICS, INC. | Vorstandsvorsitzender | 01.04.2012 |
Ehemalige bekannte Positionen von Sergio Traversa
| Unternehmen | Position | Ende |
|---|---|---|
| ACTINIUM PHARMACEUTICALS, INC. | Vorstandsvorsitzender | 16.09.2013 |
Cactus Ventures, Inc.
 Cactus Ventures, Inc. Financial ConglomeratesFinance Operates as a blank check company | Vorstandsvorsitzender | 18.04.2013 |
Actinium Pharmaceuticals, Inc. /Old/
 Actinium Pharmaceuticals, Inc. /Old/ Miscellaneous Commercial ServicesCommercial Services Develops and commercializes alpha particle immunotherapeutics | Direktor/Vorstandsmitglied | 18.04.2013 |
Medeor, Inc. | Vorstandsvorsitzender | 01.04.2012 |
Farmitalia Carlo Erba Ltd. | Vertrieb & Marketing | - |
Ausbildung von Sergio Traversa
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
26
Beziehungen ersten Grades
15
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 15 |
|---|---|
Eli Lilly & Co.
 Eli Lilly & Co. Pharmaceuticals: MajorHealth Technology Manufactures, wholesales and markets pharmaceutical products | Health Technology |
Actinium Pharmaceuticals, Inc. /Old/
Actinium Pharmaceuticals, Inc. /Old/ Miscellaneous Commercial ServicesCommercial Services Develops and commercializes alpha particle immunotherapeutics | Commercial Services |
Cactus Ventures, Inc.
Cactus Ventures, Inc. Financial ConglomeratesFinance Operates as a blank check company | Finance |
Camp Nine, Inc.
 Camp Nine, Inc. Pharmaceuticals: GenericHealth Technology Operates as a clinical stage biopharmaceutical company | Health Technology |
Therakos, Inc.
 Therakos, Inc. BiotechnologyHealth Technology Develops extracorporeal photopheresis delivery system for autologous immunomodulatory therapy | Health Technology |
ING Barings LLC
 ING Barings LLC Investment Banks/BrokersFinance Provides brokerage services | Finance |
Relmada Therapeutics, Inc. /Old/
 Relmada Therapeutics, Inc. /Old/ Pharmaceuticals: MajorHealth Technology Develops pharmaceutical drugs for the treatment of acute and chronic pains | Health Technology |
Farmitalia Carlo Erba SRL | Health Technology |
Ardana Capital Management LP
 Ardana Capital Management LP Investment ManagersFinance Ardana Capital Management manages a hedge fund that focuses on healthcare stocks | Finance |
University of Turin
 University of Turin Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Actinium Pharmaceuticals, Inc.
 Actinium Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company developing targeted payload immunotherapeutic for the treatment of advanced cancers | Health Technology |
Medeor, Inc. | |
The Leonard N Stern School of Business
 The Leonard N Stern School of Business Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Relmada Therapeutics, Inc.
 Relmada Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops drug products for the treatment of depression and other central nervous system diseases | Health Technology |
Farmitalia Carlo Erba Ltd. |
